East Ventures, a prominent venture capital firm in Indonesia and Southeast Asia, has unveiled a new $30 million “East Ventures Healthcare Fund” dedicated to advancing healthcare solutions in Indonesia. This fund is aimed at nurturing innovative startups that address the specific challenges and prospects of the Indonesian healthcare sector.

Willson Cuaca, Co-Founder and Managing Partner at East Ventures, remarked on Indonesia’s vast potential as a dynamic healthcare hub in Southeast Asia. Cuaca emphasized the fund’s intent to bolster healthcare innovation in the region and underscored East Ventures’ unwavering dedication to this cause.

Previously, the firm actively invested in regional healthcare startups, boasting 30 companies in its healthcare portfolio, which includes Mesh Bio, AMILI, Aevice Health, Etana, and more. Notably, East Ventures has been at the forefront of the genomics-based healthcare revolution, with investments in trailblazing startups like NalaGenetics and Nusantics.

Amid the COVID-19 pandemic, East Ventures pioneered several initiatives, such as the Indonesia PASTI Bisa (IDPB) in March 2020, which channeled the firm’s digital ecosystem to assist in COVID-19 mitigation efforts.

The firm’s recent endeavors also include contributions to the Biomedical & Genome Science Initiative (BGSi) and the release of a white paper in February 2023, highlighting the transformative potential of genomics in Indonesia’s healthcare landscape.